Imipramine
ATC Code
N06AA02
Imipramine
Definition
A synthetic tricyclic derivative, antidepressant Imipramine enhances monoamine neurotransmission in certain areas of the brain. It also induces sedation through histamine 1 receptor blockage; hypotension through beta-adrenergic blockage; and diverse parasympatholytic effects. Imipramine has less sedative effect than other members of its therapeutic family. It is used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. (NCI04)
Also known as 5H-Dibenz(b,f)azepine, 5-(3-(dimethylamino)propyl)-10,11-dihydro-, IMIPRAMINE — per NCIT
Also identified as
- ATC N06AA02 per RXNORM
- NCIT NCIT:C62039 per NCIT
- SCTID 36113004 per RXNORM
- SCTID 372718005 per RXNORM
- UNII OGG85SX4E4 per RXNORM
Indications
| Disease | Relation | Source |
|---|---|---|
| Attention deficit hyperactivity disorder, inattentive type | may treat | MEDRT · Public domain (U.S. Government work) |
| Depressive disorder | may treat | MEDRT · Public domain (U.S. Government work) |
| Enuresis | may treat | MEDRT · Public domain (U.S. Government work) |
| Panic disorder | may treat | MEDRT · Public domain (U.S. Government work) |